Miinalainen IJ: Difference between revisions
From Bioblast
Marte Verena (talk | contribs) No edit summary |
Marte Verena (talk | contribs) No edit summary |
||
Line 10: | Line 10: | ||
|country=Finland | |country=Finland | ||
|weblink=[www.oulu.fi/biocenter/em] | |weblink=[http://www.oulu.fi/biocenter/em] | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} |
Revision as of 14:13, 20 June 2013
Name | Miinalainen Ilkka, Ph.D. |
---|---|
Institution | Biocenter Oulu Electron Microscopy Core Facility
University of Oulu |
Address | Aapistie 5A, 90220 |
City | Oulu |
State/Province | |
Country | Finland |
[email protected] | |
Weblink | [1] |
O2k-Network Lab | IE Dublin Miinalainen I |
Labels:
Publications
Published | Reference | |
---|---|---|
Raesaenen 2016 Proc Natl Acad Sci U S A | 2016 | RΓ€sΓ€nen M, Degerman J, Nissinen TA, Miinalainen I, KerkelΓ€ R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, KivelΓ€ R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A 113:13144-49. |